Bayer has agreed to $7.25 billion proposed settlement over thousands of lawsuits alleging the company failed to warn people ...

Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a forum held Tuesday by ...

President Trump blared about the “GREAT JOBS NUMBERS” from last week’s jobs report. But a deeper look at the data shows the U ...

The FDA rejected a Disc Medicine therapy for a rare blood disorder, the first experimental drug to go through a new program ...

It’s officially been one year since Kennedy became the nation’s health secretary. He has made numerous promises and set many ...

Facing shrinking profits and higher costs, health insurers are accelerating adoption of AI throughout their sprawling ...

Payment rates for Medicare's ACCESS model, health insurers' use of AI, and more.

Also, psilocybin may be headed for approval despite mildly anticlimactic remission rates, and Ocular’s wet AMD drug does .… ...

Highly respected doctors on social media are endorsing questionable medical products — but they’re deepfakes, and they’re a ...

Compass Pathways on Tuesday disclosed results from two Phase 3 studies that support a potential approval of its psilocybin treatment for severe depression, but more detailed data are needed to ...

Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question.

You're reading the web edition of D.C. Diagnosis, STAT's guide to the ins and outs and oddities of health politics and policy ...